The SCIDOTS Project: Evidence of benefits of an integrated tobacco cessation intervention in tuberculosis care on treatment outcomes

Table 5 Smoking cessation outcomes according to group assignment

Outcome measure	DOTS (n = 46)	SCIDOTS (n = 40)	p-value^a
	Abstinence rate, no. (%)
On quit date (Week 0) ^b
7-day point prevalence abstinence	0 (0%)	0 (0%)	-
Continuous abstinence (2 weeks)	0 (0%)	0 (0%)	-
End of 3 ^rd month post quit date (Week 12) ^b
7-day point prevalence abstinence	6 (13.0%)	30 (75.0%)	< 0.001
Continuous abstinence (2 weeks)	5 (10.9%)	28 (70.0%)	< 0.001
End of 6 ^th month post quit date (Week 24) ^c
7-day point prevalence abstinence	5 (10.9%)	33 (82.5%)	< 0.001
Continuous abstinence (4 weeks)	4 (8.7%)	31 (77.5%)	< 0.001

^aChi-square (χ²) test was used in calculating p-values.
^bPatient-reported abstinence verified biochemically using breath CO analysis.
^cPatient-reported abstinence verified biochemically using breath CO analysis and saliva cotinine testing.

ISSN: 1747-597X